Skip to main content
PMC home page
Medline Book to support NIHPA logoLink to Medline Book to support NIHPA
. 2024 Feb;28(8):1–84. doi: 10.3310/HDKV1008

Use of selective gut decontamination in critically ill children: PICnIC a pilot RCT and mixed-methods study.

Alanna Brown, Paloma Ferrando-Vivas, Mariana Popa, Gema Milla de la Fuente, John Pappachan, Brian H Cuthbertson, Laura Drikite, Richard Feltbower, Theodore Gouliouris, Isobel Sale, Robert Shulman, Lyvonne N Tume, John Myburgh, Kerry Woolfall, David A Harrison, Paul R Mouncey, Kathryn Rowan, Nazima Pathan
PMCID: PMC11017160  PMID: 38421007

Abstract

BACKGROUND

Healthcare-associated infections are a major cause of morbidity and mortality in critically ill children. In adults, data suggest the use of selective decontamination of the digestive tract may reduce the incidence of healthcare-associated infections. Selective decontamination of the digestive tract has not been evaluated in the paediatric intensive care unit population.

OBJECTIVES

To determine the feasibility of conducting a multicentre, cluster-randomised controlled trial in critically ill children comparing selective decontamination of the digestive tract with standard infection control.

DESIGN

Parallel-group pilot cluster-randomised controlled trial with an integrated mixed-methods study.

SETTING

Six paediatric intensive care units in England.

PARTICIPANTS

Children (> 37 weeks corrected gestational age, up to 16 years) requiring mechanical ventilation expected to last for at least 48 hours were eligible for the PICnIC pilot cluster-randomised controlled trial. During the ecology periods, all children admitted to the paediatric intensive care units were eligible. Parents/legal guardians of recruited patients and healthcare professionals working in paediatric intensive care units were eligible for inclusion in the mixed-methods study.

INTERVENTIONS

The interventions in the PICnIC pilot cluster-randomised controlled trial included administration of selective decontamination of the digestive tract as oro-pharyngeal paste and as a suspension given by enteric tube during the period of mechanical ventilation.

MAIN OUTCOME MEASURES

The decision as to whether a definitive cluster-randomised controlled trial is feasible is based on multiple outcomes, including (but not limited to): (1) willingness and ability to recruit eligible patients; (2) adherence to the selective decontamination of the digestive tract intervention; (3) acceptability of the definitive cluster-randomised controlled trial; (4) estimation of recruitment rate; and (5) understanding of potential clinical and ecological outcome measures.

RESULTS

A total of 368 children (85% of all those who were eligible) were enrolled in the PICnIC pilot cluster-randomised controlled trial across six paediatric intensive care units: 207 in the baseline phase (Period One) and 161 in the intervention period (Period Two). In sites delivering selective decontamination of the digestive tract, the majority (98%) of children received at least one dose of selective decontamination of the digestive tract, and of these, 68% commenced within the first 6 hours. Consent for the collection of additional swabs was low (44%), though data completeness for potential outcomes, including microbiology data from routine clinical swab testing, was excellent. Recruited children were representative of the wider paediatric intensive care unit population. Overall, 3.6 children/site/week were recruited compared with the potential recruitment rate for a definitive cluster-randomised controlled trial of 3 children/site/week, based on data from all UK paediatric intensive care units. The proposed trial, including consent and selective decontamination of the digestive tract, was acceptable to parents and staff with adaptations, including training to improve consent and communication, and adaptations to the administration protocol for the paste and ecology monitoring. Clinical outcomes that were considered important included duration of organ failure and hospital stay, healthcare-acquired infections and survival.

LIMITATIONS

The delivery of the pilot cluster-randomised controlled trial was disrupted by the COVID-19 pandemic, which led to slow set-up of sites, and a lack of face-to face training.

CONCLUSIONS

PICnIC's findings indicate that a definitive cluster-randomised controlled trial in selective decontamination of the digestive tract in paediatric intensive care units is feasible with the inclusion modifications, which would need to be included in a definitive cluster-randomised controlled trial to ensure that the efficiency of trial processes is maximised.

FUTURE WORK

A definitive trial that incorporates the protocol adaptations and outcomes arising from this study is feasible and should be conducted.

TRIAL REGISTRATION

This trial is registered as ISRCTN40310490.

FUNDING

This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 16/152/01) and is published in full in Health Technology Assessment; Vol. 28, No. 8. See the NIHR Funding and Awards website for further award information.

Plain language summary

Each year, around 20,000 critically ill children are admitted to paediatric intensive care units in the UK. These children are at a higher risk of healthcare-associated infections, one of the main sources of which is the large number of bacteria in the digestive tract. Spread of bacteria from the digestive tract into other organs, such as the lung (causing ventilator-associated pneumonia) or bloodstream (causing sepsis), can be life-threatening. The risk is highest in those children whose illness is so severe that they require prolonged mechanical ventilation. Stopping the growth of bacteria in the digestive tract (called selective decontamination of the digestive tract) has been shown in adults to reduce the number of hospital-acquired infections. However, there have been no trials in children. We wanted to assess how practical and acceptable such a trial would be comparing standard infection control to selective decontamination of the digestive tract-enhanced infection control and monitoring how each intervention affected antimicrobial resistance. We undertook a pilot study to examine whether clinicians could identify eligible children, enrol them in the study and follow study procedures during the course of paediatric intensive care unit admission. Alongside this, we interviewed parents and clinicians to get their views on the proposed trial. Six hospitals recruited 559 patients over a period of roughly 7 months. Hospitals were randomly allocated to continue with the standard infection control procedure or to give selective decontamination of the digestive tract. Overall, recruitment was higher than expected. Alongside this, we examined the views of patients, caregivers and healthcare professionals to assess their views on whether a trial should be carried out to see if selective decontamination of the digestive tract should become part of the infection control regime for children most at risk of hospital-acquired infection in the paediatric intensive care unit. Overall results suggest that a larger PICnIC trial incorporating patient stakeholder and clinical staff feedback on design and outcomes is feasible and that it is appropriate to conduct a trial into the effectiveness of selective decontamination of the digestive tract administration to minimise hospital-acquired infections.

Full text of this article can be found in Bookshelf.

References

  1. Patrick SW, Kawai AT, Kleinman K, Jin R, Vaz L, Gay C, et al. Health care-associated infections among critically ill children in the US, 2007–2012. Pediatrics 2014;134(4):705–12. doi: 10.1542/peds.2014-0613. [DOI] [PubMed]
  2. Field-Ridley A, Dharmar M, Steinhorn D, McDonald C, Marcin JP. ICU-acquired weakness is associated with differences in clinical outcomes in critically ill children*. Pediatr Crit Care Med 2016;17(1):53–7. https://doi.org/10.1097/PCC.0000000000000538 doi: 10.1097/PCC.0000000000000538. [DOI] [PMC free article] [PubMed]
  3. Choong K, Al-Harbi S, Siu K, Wong K, Cheng J, Baird B, et al. Functional recovery following critical illness in children: The ‘wee-Cover’ pilot study. Pediatr Crit Care Med 2015;16(4):310–8. doi: 10.1097/PCC.0000000000000362. [DOI] [PMC free article] [PubMed]
  4. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 1999;159(4 I):1249–56. doi: 10.1164/ajrccm.159.4.9807050. [DOI] [PubMed]
  5. Bekaert M, Timsit JF, Vansteelandt S, Depuydt P, Vésin A, Garrouste-Orgeas M, et al.; Outcomerea Study Group. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med 2011;184(10):1133–9. doi: 10.1164/rccm.201105-0867OC. [DOI] [PubMed]
  6. de Smet AMGA, Kluytmans JAJW, Cooper BS, Mascini EM, Benus RFJ, van der Werf TS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009;360(1):20–31. https://doi.org/10.1056/NEJMoa0800394 doi: 10.1056/NEJMoa0800394. [DOI] [PubMed]
  7. Group TSI for the A and NZICSCT. Effect of selective decontamination of the digestive tract on hospital mortality in critically ill patients receiving mechanical ventilation: a randomized clinical trial. JAMA 2022;328(19):1911–21. https://doi.org/10.1001/jama.2022.17927 doi: 10.1001/jama.2022.17927. [DOI] [PMC free article] [PubMed]
  8. Hammond NE, Myburgh J, Seppelt I, Garside T, Vlok R, Mahendran S, et al. Association between selective decontamination of the digestive tract and in-hospital mortality in intensive care unit patients receiving mechanical ventilation: a systematic review and meta-analysis. JAMA 2022;328(19):1922–34. https://doi.org/10.1001/jama.2022.19709 doi: 10.1001/jama.2022.19709. [DOI] [PMC free article] [PubMed]
  9. Francis JJ, Duncan EM, Prior ME, MacLennan GS, Dombrowski SU, Bellingan G, et al. Selective decontamination of the digestive tract in critically ill patients treated in intensive care units: a mixed-methods feasibility study (the SuDDICU study). Health Technol Assess (Rockv) 2014;18(25):1–170. doi: 10.3310/hta18250. [DOI] [PMC free article] [PubMed]
  10. Canter RR, Harvey SE, Harrison DA, Campbell MK, Rowan KM, Cuthbertson BH; Selective Decontamination of the Digestive tract in critically ill patients treated in Intensive Care Unit (SuDDICU) Investigators. Observational study of current use of selective decontamination of the digestive tract in UK Critical Care units. B J Anaesth 2014;113(4):610–7. https://doi.org/10.1093/bja/aeu108 doi: 10.1093/bja/aeu108. [DOI] [PubMed]
  11. Daneman N, Sarwar S, Fowler RA, Cuthbertson BH. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect Dis 2013;13(4):737–8. doi: 10.1016/S1473-3099(12)70322-5. [DOI] [PubMed]
  12. Liberati A, D’Amico R, Pifferi S, Torri V, Brazzi L, Parmelli E. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev 2009;2009(4):CD000022. doi: 10.1002/14651858.CD000022.pub3. [DOI] [PMC free article] [PubMed]
  13. Oostdijk EAN, De Smet AMGA, Blok HEM, Thieme Groen ES, Van Asselt GJ, Benus RFJ, et al. Ecological effects of selective decontamination on resistant gram-negative bacterial colonization. Am J Respir Crit Care Med 2010;181(5):452–7. doi: 10.1164/rccm.200908-1210OC. [DOI] [PubMed]
  14. Plantinga NL, Bonten MJM. Selective decontamination and antibiotic resistance in ICUs. Critical Care 2015;19:259. doi: 10.1186/s13054-015-0967-9. [DOI] [PMC free article] [PubMed]
  15. Price RJ, Cuthbertson BH; SuDDICU Collaboration. Selective decontamination of the digestive tract and oropharynx: after 30 years of debate is the definitive answer in sight? Curr Opin Crit Care 2016;22(2):161–6. doi: 10.1097/MCC.0000000000000281. [DOI] [PubMed]
  16. Petros A, Silvestri L, Booth R, Taylor N, Van Saene H. Selective decontamination of the digestive tract in critically ill children: systematic review and meta-analysis. Pediatr Crit Care Med 2013;14(1):89–97. doi: 10.1097/PCC.0b013e3182417871. [DOI] [PubMed]
  17. Woolfall K, Frith L, Dawson A, Gamble C, Lyttle M, Young B. Fifteen-minute consultation: an evidence-based approach to research without prior consent (deferred consent) in neonatal and paediatric critical care trials. Archiv Dis Child: Educ Pract 2016;101:49–53. doi: 10.1136/archdischild-2015-309245. [DOI] [PMC free article] [PubMed]
  18. Straney L, Clements A, Parslow RC, Pearson G, Shann F, Alexander J, Slater A; ANZICS Paediatric Study Group and the Paediatric Intensive Care Audit Network. Paediatric index of mortality 3: an updated model for predicting mortality in pediatric intensive care*. Pediatr Crit Care Med 2013;14(7):673–81. https://doi.org/10.1097/PCC.0b013e31829760cf doi: 10.1097/PCC.0b013e31829760cf. [DOI] [PubMed]
  19. Health Services Research Unit. Cluster Sample Size Calculator: User Manual. Foresterhill: University of Aberdeen; 1999. URL: www.abdn.ac.uk/hsru/documents/calculationmanual.pdf (accessed 15 August 2023).
  20. Moher D, Schulz KF, Altman D, Group for the C. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285(15):1987–91. https://doi.org/10.1001/jama.285.15.1987 doi: 10.1001/jama.285.15.1987. [DOI] [PubMed]
  21. Campbell MK, Piaggio G, Elbourne DR, Altman DG;CONSORT Group. Consort 2010 statement: extension to cluster randomised trials. BMJ 2012;345(7881):e5661. doi: 10.1136/bmj.e5661. [DOI] [PubMed]
  22. Deja E, Peters MJ, Khan I, Mouncey PR, Agbeko R, Fenn B, et al. Establishing and augmenting views on the acceptability of a paediatric critical care randomised controlled trial (the FEVER trial): a mixed methods study. BMJ Open 2021;11(3):e041952. doi: 10.1136/bmjopen-2020-041952. [DOI] [PMC free article] [PubMed]
  23. Deja E, Roper L, Tume LN, Dorling J, Gale C, Arch B, et al. Can they stomach it? Parent and practitioner acceptability of a trial comparing gastric residual volume measurement versus no gastric residual volume in UK NNU and PICUs: a feasibility study. Pilot Feasibility Stud 2021;7(1):49. doi: 10.1186/s40814-021-00784-5. [DOI] [PMC free article] [PubMed]
  24. Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res 2016;26(13):1753–60. doi: 10.1177/1049732315617444. [DOI] [PubMed]
  25. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3(2):77–101.
  26. Glaser BG. The constant comparative method of qualitative analysis. Soc Probl 1965;12(4):436–45.
  27. Morse JM, Barrett M, Mayan M, Olson K, Spiers J. Verification strategies for establishing reliability and validity in qualitative research. Int J Qual Methods 2002;1(2):13–22.

RESOURCES